Global Ruxolitinib Market Forecasts Strong Growth Amid Rising Demand for Targeted Therapies Read More => https://dataintelo.com/report/global-ruxolitinib-market The Ruxolitinib Market is witnessing steady expansion, driven by increasing prevalence of myeloproliferative disorders and advancements in Janus kinase (JAK) inhibitor therapies. As targeted treatment solutions gain ground over conventional options, the global demand for Ruxolitinib continues to rise, offering new hope for patients and lucrative prospects for the healthcare industry.